Biological Trace Element Research

, Volume 137, Issue 3, pp 335–339

Diminished Selenium Levels in Hemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients

  • Maryam Pakfetrat
  • Leila Malekmakan
  • Mahshid Hasheminasab
Article

Abstract

In this cross-sectional study, selenium (Se) levels in the sera of 35 hemodialysis (HD) patients and 34 patients undergoing continuous ambulatory peritoneal dialysis (CAPD) for more than 3 months were compared with the serum Se levels of 34 healthy volunteers. The observed Se levels of 100.8 ± 51.9 µg/L in the sera of the HD patients and of 65.5 ± 32.1 µg/L in the sera of the CAPD patients were significantly lower than the 134.9 ± 81.2 µg/L of the controls, with p = 0.002 and 0.02, respectively. Furthermore, the Se levels were significantly higher in the HD rather than the CAPD patients (p = 0.01). In the spent dialysate effluent fluid of 32 of the CAPD patients Se was undetectable, in the remaining two CAPD patients the Se levels were 1.9 and 4.6μg/l, respectively. The low Se levels of HD and CAPD patients as compared to healthy persons are attributed to diminished Se retention due to chronic oxidative stress.

Keywords

Hemodialysis Peritoneal dialysis Selenium 

References

  1. 1.
    Olszewska M (2004) The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure. Ann Acad Med Stetin 50(1):41–52PubMedGoogle Scholar
  2. 2.
    Yavuz O, Bicik Z, Cinar Y et al (2004) The effect of different dialysis membranes on oxidative stress and selenium status. Clinica Chimica Acta 346(2):153–160CrossRefGoogle Scholar
  3. 3.
    Adamowicz A, Trafikowska U, Trafikowska A et al (2002) Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis. Med Sci Monit 8(3):202–205Google Scholar
  4. 4.
    Zagrodzki P, Bartoń H, Walas S et al (2007) Selenium status indices, laboratory data, and selected biochemical parameters in end-stage renal disease patients. Biol Trace Elem Res 116(1):29–41CrossRefPubMedGoogle Scholar
  5. 5.
    Letavayova L, Vlˇckova V, Brozmanova J (2006) Selenium: from cancer prevention to DNA damage. Toxicology 227:1–14CrossRefPubMedGoogle Scholar
  6. 6.
    Ravn-Haren G, Bugel S, Krath BN et al (2008) A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: effects on oxidative defence regulation. Br J Nutr 99:883–892PubMedGoogle Scholar
  7. 7.
    Milly K, Wit L, Diskin C et al (1992) Selenium in renal failure patients. Nephron 61:139–144CrossRefPubMedGoogle Scholar
  8. 8.
    Zachara BA, Adamowicz A, Trafikowska U et al (2000) Decreased plasma glutathione peroxidase activity in uremic patients. Nephron 84:278–279CrossRefPubMedGoogle Scholar
  9. 9.
    Zachara BA, Trafikowska U, Adamowicz A et al (2001) Selenium, glutathione peroxidase, and some other antioxidant parameters in blood of patients with chronic renal failure. J Trace Elements Med Biol 15:161–166CrossRefGoogle Scholar
  10. 10.
    Chen B, Lamberts LV, Behets GJ et al (2009) Selenium, lead, and cadmium levels in renal failure patients in China. Biol Trace Elem Res 131(1):1–12CrossRefPubMedGoogle Scholar
  11. 11.
    Nhien NV, Khan NC, Yabutani T et al (2008) Relationship of low serum selenium to anemia among primary school children living in rural Vietnam. J Nutr Sci Vitaminol 54(6):454–459CrossRefPubMedGoogle Scholar
  12. 12.
    Bellinger FP, Raman AV, Reeves MA et al (2009) Regulation and function of selenoproteins in human disease. Biochem J 422(1):11–22CrossRefPubMedGoogle Scholar
  13. 13.
    Bogye G, Tompos G, Alfthan G (2000) Selenium depletion in hemodialysis patients treated with polysulfone membranes. Nephron 84:119–123CrossRefPubMedGoogle Scholar
  14. 14.
    Harrison I, Littlejohn D, Fell GS (1996) Distribution of selenium in human blood plasma and serum. Analyst 121:189–194CrossRefPubMedGoogle Scholar
  15. 15.
    Plecko T, Rükgauer M, Kruse-Jarres JD (1998) Distribution of human plasma selenium and its role in the antioxidant system. Metal Ions Biol Med 5:385–389Google Scholar
  16. 16.
    Nichol C, Herdman J, Sattar N et al (1998) Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clin Chem 44:1764–1766PubMedGoogle Scholar
  17. 17.
    Sataar N, Fell GS, Harrison I et al. (1996) Are the low concentrations of plasma Se observed in some severly ill patients due to the acute phase response to inflammation, injury and sepsis? In: Program and Abstract Book of the 6th International Symposium in Selenium in Biology and Medicine, Beijing, p 80Google Scholar
  18. 18.
    Dworkin B, Weseley S, Rosenthal WS et al (1987) Diminished blood selenium levels in renal failure patients on dialysis: correlations with nutritional status. Am J Med Sci 293(1):6–12CrossRefPubMedGoogle Scholar
  19. 19.
    Apostolidis NS, Panoussopoulos DG, Stamou KM et al (2002) Selenium metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 22(3):400–404PubMedGoogle Scholar
  20. 20.
    Park T, Cho K, Park SH et al (2009) Taurine normalizes blood levels and urinary loss of selenium, chromium, and manganese in rats chronically consuming alcohol. Adv Exp Med Biol 643:407–414CrossRefPubMedGoogle Scholar
  21. 21.
    Sriram K, Abraham G (2000) Loss of zinc and selenium does not occur through peritoneal dialysis. Nutrition 16(11–12):1047–1051CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Maryam Pakfetrat
    • 1
  • Leila Malekmakan
    • 1
  • Mahshid Hasheminasab
    • 1
  1. 1.Shiraz Nephro-Urology Research CenterShiraz University of Medical SciencesShirazIran

Personalised recommendations